Collaborative Fund Advisors LLC Makes New Investment in Neurocrine Biosciences, Inc. $NBIX
Collaborative Fund Advisors LLC purchased a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,293 shares of the company’s stock, valued at approximately $434,000. Other institutional investors and hedge funds have also […]
6 Jul 09:03 · The Markets Daily